The company is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States
Read More
The company plans to produce 200 million doses of COVAXIN per annum in the good manufacturing practice (GMP) facilities that are already operational for the production of vaccines based on Inactivated Vero Cell Platform Technology,
Read More
The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious.
Read More
Favipiravir is close to Remdesivir, in that Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases
Read More
India, he said, has recently launched a production linked incentive scheme that will provide the US companies new opportunities for investment.
Read More
Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.
Read More
He said the Delhi government will make efforts to speed-up the purchases further and administer jabs to people as soon as possible after the inoculation drive opens up on Saturday for everybody above 18.
Read More
Bharat Biotech will produce 30 million doses of its COVID-19 vaccine, Covaxin, next month against 15 million doses in March to support vaccination campaign in the country, its chairman and managing director Krishna Ella said on Tuesday.
Read More
This compared to Rs 150 per dose it charges the central government for the existing supplies.
Read More
Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell their products to India.
Read More
